LENS - プレスビア (Presbia PLC) プレスビア

 LENSのチャート


 LENSの企業情報

symbol LENS
会社名 Presbia PLC (プレスビア)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia the age-related loss of the ability to focus on near objects. The Company's segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company's lens referred to as the microlens is a miniature lens designed to be surgically implanted in a patient's eye to improve that patient's ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company's solution is a standalone solution for plano presbyopes or those individuals suffering from presbyopia but do not have any other visual disorders.   プレスビアはアイルランドの工学レンズのインプラント会社。主に老眼矯正レンズを扱う。同社の老眼矯正用レンズPresbia Flexivue Microlensは直径3mmの小型レンズで、フェムト秒レ―ザによって作成された角膜ポケットに移植され、交換、取り外し可能なように設計されている。   Operates as an ophthalmic device company
本社所在地 Suite 7 Sandyford Office Centre 17 Corrig Road Sandyford Dublin 18 IRL
代表者氏名 Mark T. Yung Mark T. Yung
代表者役職名 Executive Chairman of the Board 取締役会長
電話番号 +353 1-551-1487
設立年月日 41671
市場名 NASDAQ Small Cap
ipoyear 2015年
従業員数 24人
url www.presbia.com
nasdaq_url https://www.nasdaq.com/symbol/lens
adr_tso
EBITDA EBITDA(百万ドル) -11.40900
終値(lastsale) 1.72
時価総額(marketcap) 29579104.88
時価総額 時価総額(百万ドル) 20.93174
売上高 売上高(百万ドル) 0.01500
企業価値(EV) 企業価値(EV)(百万ドル) 18.08574
当期純利益 当期純利益(百万ドル) -11.93700
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Presbia PLC revenues increased 20% to $6K. Net loss decreased 53% to $4.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Research and development decrease of 56% to $1.7M (expense) General and administrative decrease of 48% to $1.8M (expense) Sales and marketing decrease of 60% to $713K (expense).

 LENSのテクニカル分析


 LENSのニュース

   CLDR, TLRD, MDB and WAGE among midday movers  2019/03/14 16:44:41 Seeking Alpha
   Atossa Genetics leads healthcare gainers; Seelos Therapeutics and Presbia among losers  2019/03/14 15:01:48 Seeking Alpha
   Thinking about buying stock in Akari Therapeutics, Presbia Plc, Roku Inc., Snap Inc., or Pareteum Corp.?  2019/03/14 13:31:00 Benzinga
NEW YORK , March 14, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AKTX, LENS, ROKU, SNAP, and TEUM. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. AKTX: Full story available on Benzinga.com
   DG, TLRD and CLDR among premarket losers  2019/03/14 13:16:41 Seeking Alpha
   Thinking about buying stock in Akari Therapeutics, Presbia Plc, Roku Inc., Snap Inc., or Pareteum Corp.?  2019/03/14 09:31:00 Benzinga
NEW YORK, March 14, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AKTX, LENS, ROKU, SNAP, and TEUM. To see how …
   CLDR, TLRD, MDB and WAGE among midday movers  2019/03/14 16:44:41 Seeking Alpha
   Atossa Genetics leads healthcare gainers; Seelos Therapeutics and Presbia among losers  2019/03/14 15:01:48 Seeking Alpha
   Thinking about buying stock in Akari Therapeutics, Presbia Plc, Roku Inc., Snap Inc., or Pareteum Corp.?  2019/03/14 13:31:00 Benzinga
NEW YORK , March 14, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AKTX, LENS, ROKU, SNAP, and TEUM. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. AKTX: Full story available on Benzinga.com
   DG, TLRD and CLDR among premarket losers  2019/03/14 13:16:41 Seeking Alpha
   Thinking about buying stock in Akari Therapeutics, Presbia Plc, Roku Inc., Snap Inc., or Pareteum Corp.?  2019/03/14 09:31:00 Benzinga
NEW YORK, March 14, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AKTX, LENS, ROKU, SNAP, and TEUM. To see how …
   CLDR, TLRD, MDB and WAGE among midday movers  2019/03/14 16:44:41 Seeking Alpha
   Atossa Genetics leads healthcare gainers; Seelos Therapeutics and Presbia among losers  2019/03/14 15:01:48 Seeking Alpha
   Thinking about buying stock in Akari Therapeutics, Presbia Plc, Roku Inc., Snap Inc., or Pareteum Corp.?  2019/03/14 13:31:00 Benzinga
NEW YORK , March 14, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AKTX, LENS, ROKU, SNAP, and TEUM. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. AKTX: Full story available on Benzinga.com
   DG, TLRD and CLDR among premarket losers  2019/03/14 13:16:41 Seeking Alpha
   Thinking about buying stock in Akari Therapeutics, Presbia Plc, Roku Inc., Snap Inc., or Pareteum Corp.?  2019/03/14 09:31:00 Benzinga
NEW YORK, March 14, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AKTX, LENS, ROKU, SNAP, and TEUM. To see how …

 関連キーワード  (先端医療機器_テクノロジ― 米国株 プレスビア LENS Presbia PLC)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)